{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+3&page=88", "query": { "intervention": "Part 3", "page": 88 }, "page_size": 10 }, "pagination": { "page": 88, "page_size": 10, "total_count": 4023, "total_pages": 403, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+3&page=89&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+3&page=87&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-12T22:44:59.168Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07916818", "title": "High-Tech, High-Touch", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress (Psychology)", "Resilience, Psychological", "Anxiety", "Depressive Symptoms", "Well-being", "Sleep Quality" ], "interventions": [ { "name": "Wearable ring with continuous biometric monitoring", "type": "DEVICE" }, { "name": "AI health coaching application", "type": "BEHAVIORAL" }, { "name": "Osteopathic manipulative treatment (OMT)", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL", "OTHER" ], "sponsor": "Touro University, California", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 43, "start_date": "2024-11-17", "completion_date": "2026-01-02", "has_results": false, "last_update_posted_date": "2026-11-04", "last_synced_at": "2026-11-12T22:44:59.168Z", "location_count": 1, "location_summary": "Vallejo, California", "locations": [ { "city": "Vallejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07916818" }, { "nct_id": "NCT06528691", "title": "Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "High Grade Glioma", "CNS Tumor" ], "interventions": [ { "name": "Entrectinib", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "G-CSF", "type": "BIOLOGICAL" }, { "name": "Pegfilgrastim", "type": "BIOLOGICAL" }, { "name": "Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "PROCEDURE" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "3 Years", "sex": "ALL", "summary": "Up to 3 Years" }, "enrollment_count": 52, "start_date": "2026-05-01", "completion_date": "2032-11", "has_results": false, "last_update_posted_date": "2026-11-03", "last_synced_at": "2026-11-12T22:44:59.168Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06528691" }, { "nct_id": "NCT03199196", "title": "Using Social Networks to Promote Physical Activity in African American and Hispanic Women", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer Prevention" ], "interventions": [ { "name": "Activity Tracker", "type": "DEVICE" }, { "name": "Smartphone Application", "type": "DEVICE" }, { "name": "Questionnaires", "type": "BEHAVIORAL" }, { "name": "Focus Group", "type": "BEHAVIORAL" }, { "name": "Electronic Newsletters", "type": "BEHAVIORAL" }, { "name": "Telephone Counseling", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "60 Years", "sex": "FEMALE", "summary": "25 Years to 60 Years · Female only" }, "enrollment_count": 101, "start_date": "2014-05-02", "completion_date": "2026-05-30", "has_results": false, "last_update_posted_date": "2023-04-18", "last_synced_at": "2026-11-12T22:44:59.168Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03199196" }, { "nct_id": "NCT04398680", "title": "A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Belantamab mafodotin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2021-04-20", "completion_date": "2025-11-04", "has_results": false, "last_update_posted_date": "2025-12-04", "last_synced_at": "2026-11-12T22:44:59.168Z", "location_count": 8, "location_summary": "Tucson, Arizona • Beverly Hills, California • Plantation, Florida + 5 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Plantation", "state": "Florida" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04398680" }, { "nct_id": "NCT04206332", "title": "Trial to Evaluate CIS43LS in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Malaria" ], "interventions": [ { "name": "VRC-MALMAB0100-00-AB", "type": "DRUG" }, { "name": "Plasmodium falciparum (P. falciparum) sporozoite challenge", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 71, "start_date": "2020-01-07", "completion_date": "2022-02-28", "has_results": true, "last_update_posted_date": "2023-04-18", "last_synced_at": "2026-11-12T22:44:59.168Z", "location_count": 2, "location_summary": "Baltimore, Maryland • Bethesda, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04206332" }, { "nct_id": "NCT03929744", "title": "A Study of LY3502970 in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "LY3502970", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Simvastatin", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 133, "start_date": "2019-06-12", "completion_date": "2020-11-02", "has_results": true, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-11-12T22:44:59.168Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03929744" }, { "nct_id": "NCT03948763", "title": "A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neoplasms", "Carcinoma, Non-Small-Cell Lung", "Pancreatic Neoplasms", "Colorectal Neoplasms" ], "interventions": [ { "name": "V941", "type": "BIOLOGICAL" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2019-06-26", "completion_date": "2022-08-25", "has_results": true, "last_update_posted_date": "2025-01-28", "last_synced_at": "2026-11-12T22:44:59.168Z", "location_count": 10, "location_summary": "Gilbert, Arizona • Duarte, California • San Francisco, California + 7 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03948763" }, { "nct_id": "NCT01923311", "title": "Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Acquired Immune Deficiency Syndrome (AIDS)", "HIV Infections" ], "interventions": [ { "name": "EVG", "type": "DRUG" }, { "name": "Background regimen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Weeks", "maximum_age": "17 Years", "sex": "ALL", "summary": "4 Weeks to 17 Years" }, "enrollment_count": 31, "start_date": "2013-08-26", "completion_date": "2017-11-03", "has_results": true, "last_update_posted_date": "2018-08-09", "last_synced_at": "2026-11-12T22:44:59.168Z", "location_count": 3, "location_summary": "Aurora, Colorado • Durham, North Carolina • Memphis, Tennessee", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01923311" }, { "nct_id": "NCT03876106", "title": "A Study of LUT014 in Patients With Metastatic Colorectal Cancer With EGFR Inhibitor Induced Acneiform Lesions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "EGFR Inhibitor Induced Acneiform Lesions" ], "interventions": [ { "name": "LUT014", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lutris Pharma Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2019-08-21", "completion_date": "2020-11-18", "has_results": false, "last_update_posted_date": "2022-04-06", "last_synced_at": "2026-11-12T22:44:59.168Z", "location_count": 4, "location_summary": "Los Angeles, California • St Louis, Missouri • New York, New York + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03876106" }, { "nct_id": "NCT03334266", "title": "Preventing Early Childhood Obesity, Part 2: Family Spirit Nurture, Prenatal - 18 Months", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Infant Obesity", "Mother-Child Relations", "Dietary Habits", "Breast Feeding", "Physical Activity", "Childhood Obesity", "Feeding Behavior" ], "interventions": [ { "name": "Family Spirit Nurture (FSN)", "type": "BEHAVIORAL" }, { "name": "Injury Prevention Education (IPE)", "type": "OTHER" }, { "name": "Optimized Standard Care (OSC)", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "14 Years", "maximum_age": "24 Years", "sex": "FEMALE", "summary": "14 Years to 24 Years · Female only" }, "enrollment_count": 259, "start_date": "2017-09-25", "completion_date": "2023-02-28", "has_results": false, "last_update_posted_date": "2023-03-06", "last_synced_at": "2026-11-12T22:44:59.168Z", "location_count": 3, "location_summary": "Fort Defiance, Arizona • Whiteriver, Arizona • Shiprock, New Mexico", "locations": [ { "city": "Fort Defiance", "state": "Arizona" }, { "city": "Whiteriver", "state": "Arizona" }, { "city": "Shiprock", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT03334266" } ] }